Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Cenobamate (YKP3089) protects against MES induced seizures in mice with an ED50 of 9
with slightly lesser potency toward 5-HT6
CEP-40783 in combination with erlotinib demonstrate superior anti-tumor efficacy compared to CEP-40783 and erlotinib single agents in the one erlotinib-sensitive model evaluated
is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM
InChi: InChI=1S/C19H15I4NO6S/c1-8(25)31-7-16(26)24-15(19(28)29)4-9-2-13(22)18(14(23)3-9)30-10-5-11(20)17(27)12(21)6-10/h2-3
3α, 7α-Dihydroxycoprostanic acid Catalog No.:M23573-C Cenobamate (YKP3089) protects against MES3,7 Dihydroxycoprostanic acid is an endogenous metabolite. 3,7 Dihydroxycoprostanic acid, a bile acid, is the precursor to chenodeoxycholic acid. Product information CAS Number: 17974 66 2 Molecular Weight: 434. 65 Formula: C27H46O4 Chemical Name: (6R) 6 [(1R,3aS,3bR,4R,5aS,7R,9aS,9bS,11aR) 4,7 dihydroxy 9a,11a dimethyl hexadecahydro 1H cyclopenta[a]phenanthren 1 yl] 2 methylheptanoic acid Smiles: